This post breaks down what is currently known about AOD 9604, highlights potential risks, and offers practical advice for those interested in its use
After reviewing literature and conducting a two-round Delphi survey with 42 experts, a consensus emerged that emphasizes prioritizing clinical symptoms in diagnosis, with serum B12 as a screening marker supported by methylmalonic acid or homocysteine levels for additional confirmation
Mouse obesity does not reproduce all forms of human obesity
All products include third-party purity testing and Certificate of Analysis
In rare cases, B12 injections can cause more serious side effects
The safety profile of AOD-9604 is favorable compared to many metabolic interventions, with clinical trials involving approximately 900 participants demonstrating good tolerability and minimal side effects